Skip to main content

Sirnaomics-logo

Sirnaomics Inc. has taken in yet another $11 million in investments, closing a Series C funding round that totaled $47 million.

The Gaithersburg biopharmaceutical company kicked off the round last year with $25 million in Series C1 financing — one of the biggest venture deals of the year last year in a generous overall haul for Maryland biotech companies. That was followed by an $11 million raise as part of a Series C2 round in January.

{iframe}https://biobuzz.inloop.com/en/article/71223?utm_source=ElasticEmail-sb-biobizHub&utm_medium=newsletter&utm_campaign=biobizHub-563-s-en-080519&itd_did=563&itd_uid=3432{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.